Search by Drug Name or NDC

    NDC 69842-0973-30 Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride 60; 120 mg/1; mg/1 Details

    Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride 60; 120 mg/1; mg/1

    Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride is a ORAL TABLET, EXTENDED RELEASE in the HUMAN OTC DRUG category. It is labeled and distributed by CVS Pharmacy. The primary component is FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE.

    Product Information

    NDC 69842-0973
    Product ID 69842-973_07060ec7-8d0c-40db-a42d-c6b2f8d66d3b
    Associated GPIs
    GCN Sequence Number 036868
    GCN Sequence Number Description fexofenadine/pseudoephedrine TAB ER 12H 60MG-120MG ORAL
    HIC3 Z2O
    HIC3 Description 2ND GEN ANTIHISTAMINE AND DECONGESTANT COMBINATION
    GCN 63565
    HICL Sequence Number 016846
    HICL Sequence Number Description FEXOFENADINE HCL/PSEUDOEPHEDRINE HCL
    Brand/Generic Generic
    Proprietary Name Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name FEXOFENADINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 60; 120
    Active Ingredient Units mg/1; mg/1
    Substance Name FEXOFENADINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE
    Labeler Name CVS Pharmacy
    Pharmaceutical Class Adrenergic alpha-Agonists [MoA], Histamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], alpha-Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA090818
    Listing Certified Through 2024-12-31

    Package

    NDC 69842-0973-30 (69842097330)

    NDC Package Code 69842-973-30
    Billing NDC 69842097330
    Package 1 BLISTER PACK in 1 CARTON (69842-973-30) / 30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
    Marketing Start Date 2020-08-27
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 45d3ad69-a80a-4f91-9c9b-8b19a30144a3 Details

    Revised: 9/2020